Literature DB >> 18955829

Plasma levels of TNF-alpha, IL-6, and IL-10 and their relationship with left ventricular diastolic function in patients with stable angina pectoris and preserved left ventricular systolic performance.

Wojciech Kosmala1, Roksolana Derzhko, Monika Przewlocka-Kosmala, Alina Orda, Walentyna Mazurek.   

Abstract

AIMS: The role of inflammation--a key factor underlying coronary artery disease (CAD) and systolic heart failure--in promotion of left ventricular (LV) diastolic dysfunction has not been investigated extensively so far. The aim of this study was: (i) to evaluate plasma levels of TNF-alpha, IL-6, and IL-10 in patients with stable CAD and preserved LV systolic function and (ii) to assess their relationships with LV diastolic function.
METHODS: The study population consisted of 126 patients with single vessel and 58 patients with multivessel stable CAD and LV ejection fraction >50%, and 39 healthy controls. Each participant underwent echocardiographic study including estimation of LV diastolic function indices: peak velocities of early (E) and late (A) transmitral flows, deceleration time of E wave, isovolumic relaxation time, E wave (ETT) and A wave (ATT) transit time to the LV outflow tract, and flow propagation velocity of E wave (Ep). Plasma TNF-alpha, IL-6, and IL-10 levels were evaluated by radioimmunometric method.
RESULTS: Patients with CAD presented higher TNF-alpha and IL-6 levels and higher values of IL-6/IL-10 and TNF-alpha/IL-10 ratio than the controls. IL-6 levels were higher in patients with multivessel disease than in those with single vessel disease. Significant correlations (all P<0.001) were found for TNF-alpha and Ep (r=-0.41), E/Ep (r=0.45), and ETT (r=0.38). IL-6 correlated with Ep (r=-0.39) and E/A (r=-0.33), whereas IL-10 with ETT (r=0.37), Ep (r=-0.44), and E/Ep (r=0.46).
CONCLUSION: In patients with stable CAD and preserved LV systolic performance, plasma levels of TNF-alpha and IL-6 are elevated and there is association between immunoinflammatory activation reflected by plasma levels of cytokines and LV diastolic dysfunction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18955829     DOI: 10.1097/MCA.0b013e3282fc617c

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN: 0954-6928            Impact factor:   1.439


  18 in total

1.  Fatigue, inflammation, and projected mortality in heart failure.

Authors:  Anne M Fink; Rosalia C Gonzalez; Tadeusz Lisowski; Maria Pini; Giamila Fantuzzi; Wayne C Levy; Mariann R Piano
Journal:  J Card Fail       Date:  2012-09       Impact factor: 5.712

2.  Inflammatory markers and incident heart failure risk in older adults: the Health ABC (Health, Aging, and Body Composition) study.

Authors:  Andreas Kalogeropoulos; Vasiliki Georgiopoulou; Bruce M Psaty; Nicolas Rodondi; Andrew L Smith; David G Harrison; Yongmei Liu; Udo Hoffmann; Douglas C Bauer; Anne B Newman; Stephen B Kritchevsky; Tamara B Harris; Javed Butler
Journal:  J Am Coll Cardiol       Date:  2010-05-11       Impact factor: 24.094

3.  Early detection of cardiac alterations by left atrial strain in patients with risk for cardiac abnormalities with preserved left ventricular systolic and diastolic function.

Authors:  Kerstin Braunauer; Elisabeth Pieske-Kraigher; Evgeny Belyavskiy; Radhakrishnan Aravind-Kumar; Martin Kropf; Robin Kraft; Athanasios Frydas; Esteban Marquez; Engin Osmanoglou; Carsten Tschöpe; Frank Edelmann; Burkert Pieske; Hans-Dirk Düngen; Daniel A Morris
Journal:  Int J Cardiovasc Imaging       Date:  2017-11-23       Impact factor: 2.357

Review 4.  TNFα in myocardial ischemia/reperfusion, remodeling and heart failure.

Authors:  Petra Kleinbongard; Rainer Schulz; Gerd Heusch
Journal:  Heart Fail Rev       Date:  2011-01       Impact factor: 4.214

5.  Diastolic dysfunction and contrast-induced nephropathy in patients undergoing coronary angiography.

Authors:  S Acikel; R Akdemir; H Kilic; G Cagirci; M Dogan; A B Yesilay; E Yeter
Journal:  Herz       Date:  2014-11-30       Impact factor: 1.443

6.  Impaired diastolic function in naïve untreated human immunodeficiency virus infected patients.

Authors:  Ugo Oliviero; Giovanni Bonadies; Giorgio Bosso; Maria Foggia; Valentina Apuzzi; Mariarosaria Cotugno; Antonio Valvano; Enrico Leonardi; Guglielmo Borgia; Giuseppe Castello; Raffaele Napoli; Luigi Saccà
Journal:  World J Cardiol       Date:  2010-04-26

7.  Interplay Between Inflammation and Hemostasis in Patients with Coronary Artery Disease.

Authors:  Medha Rajappa; Binita Goswami; A Balasubramanian; Baidarbhi Chakraborty; S Kumar
Journal:  Indian J Clin Biochem       Date:  2014-05-25

8.  Soluble tumor necrosis factor receptors and heart failure risk in older adults: Health, Aging, and Body Composition (Health ABC) Study.

Authors:  Catherine N Marti; Hassan Khan; Douglas L Mann; Vasiliki V Georgiopoulou; Kirsten Bibbins-Domingo; Tamara Harris; Annemarie Koster; Anne Newman; Stephen B Kritchevsky; Andreas P Kalogeropoulos; Javed Butler
Journal:  Circ Heart Fail       Date:  2013-12-09       Impact factor: 8.790

9.  Left ventricular morphology and function in patients with rheumatoid arthritis.

Authors:  L'ubomír Tomáš; Ivica Lazúrová; Mária Oetterová; Lýdia Pundová; Darina Petrášová; Martin Studenčan
Journal:  Wien Klin Wochenschr       Date:  2013-04-12       Impact factor: 1.704

10.  Cardiovascular disease is associated with COPD severity and reduced functional status and quality of life.

Authors:  Jennifer L Black-Shinn; Gregory L Kinney; Anastasia L Wise; Elizabeth A Regan; Barry Make; Mori J Krantz; R Graham Barr; James R Murphy; David Lynch; Edwin K Silverman; James D Crapo; John E Hokanson
Journal:  COPD       Date:  2014-05-15       Impact factor: 2.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.